IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i24p9285-d460915.html
   My bibliography  Save this article

Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae : A Multicenter Study in China

Author

Listed:
  • Xuemei Zhen

    (Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, (National Health Commission (NHC) Key Laboratory of Health Economics and Policy Research, Shandong University), Jinan 250012, China
    Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China)

  • Cecilia Stålsby Lundborg

    (Department of Global Public Health, Karolinska Institutet, 17177 Stockholm, Sweden)

  • Xueshan Sun

    (Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China)

  • Xiaoqian Hu

    (Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China
    College of Politics and Public Administration, Qingdao University, Qingdao 266061, China)

  • Hengjin Dong

    (Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China
    The Fourth Affiliated Hospital Zhejiang University School of Medicine, No. N1, Shancheng Avenue, Yiwu 322000, China)

Abstract

Quantifying economic and clinical outcomes for interventions could help to reduce third-generation cephalosporin resistance and Escherichia coli or Klebsiella pneumoniae . We aimed to compare the differences in clinical and economic burden between third-generation cephalosporin-resistant E. coli (3GCREC) and third-generation cephalosporin-susceptible E. coli (3GCSEC) cases, and between third-generation cephalosporin-resistant K. pneumoniae (3GCRKP) and third-generation cephalosporin-susceptible K. pneumoniae (3GCSKP) cases. A retrospective and multicenter study was conducted. We collected data from electronic medical records for patients who had clinical samples positive for E. coli or K. pneumoniae isolates during 2013 and 2015. Propensity score matching (PSM) was conducted to minimize the impact of potential confounding variables, including age, sex, insurance, number of diagnoses, Charlson comorbidity index, admission to intensive care unit, surgery, and comorbidities. We also repeated the PSM including length of stay (LOS) before culture. The main indicators included economic costs, LOS and hospital mortality. The proportions of 3GCREC and 3GCRKP in the sampled hospitals were 44.3% and 32.5%, respectively. In the two PSM methods, 1804 pairs and 1521 pairs were generated, and 1815 pairs and 1617 pairs were obtained, respectively. Compared with susceptible cases, those with 3GCREC and 3GCRKP were associated with significantly increased total hospital cost and excess LOS. Inpatients with 3GCRKP were significantly associated with higher hospital mortality compared with 3GCSKP cases, however, there was no significant difference between 3GCREC and 3GCSEC cases. Cost reduction and outcome improvement could be achieved through a preventative approach in terms of both antimicrobial stewardship and preventing the transmission of organisms.

Suggested Citation

  • Xuemei Zhen & Cecilia Stålsby Lundborg & Xueshan Sun & Xiaoqian Hu & Hengjin Dong, 2020. "Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae : A Multicenter Study in China," IJERPH, MDPI, vol. 17(24), pages 1-12, December.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:24:p:9285-:d:460915
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/24/9285/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/24/9285/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Joanna Coast & Richard Smith & Anne‐Marie Karcher & Paula Wilton & Michael Millar, 2002. "Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?," Health Economics, John Wiley & Sons, Ltd., vol. 11(7), pages 637-647, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lucy Abel & Bethany Shinkins & Alison Smith & Andrew J. Sutton & Gurdeep S. Sagoo & Ijeoma Uchegbu & A. Joy Allen & Sara Graziadio & Eoin Moloney & Yaling Yang & Peter Hall, 2019. "Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives," Medical Decision Making, , vol. 39(7), pages 857-866, October.
    2. David H. Howard, 2004. "Resistance‐induced antibiotic substitution," Health Economics, John Wiley & Sons, Ltd., vol. 13(6), pages 585-595, June.
    3. Yoel Lubell & Thomas Althaus & Stuart D Blacksell & Daniel H Paris & Mayfong Mayxay & Wirichada Pan-Ngum & Lisa J White & Nicholas P J Day & Paul N Newton, 2016. "Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings," PLOS ONE, Public Library of Science, vol. 11(3), pages 1-13, March.
    4. Barlow, Euan & Morton, Alec & Megiddo, Itamar & Colson, Abigail, 2022. "Optimal subscription models to pay for antibiotics," Social Science & Medicine, Elsevier, vol. 298(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:24:p:9285-:d:460915. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.